EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Conversion From Immediate-Release to Prolonged-Release Tacrolimus in Kidney Transplant Patients With Tremor: A Case Series Study

Dorota Kamińska, Roman Hożejowski, Andrzej Chamienia, Alicja Dębska-Ślizień, Ilona Idasiak-Piechocka, Andrzej Oko, Iwona Baranowicz-Gąszczyk, Wojciech Załuska, Oktawia Mazanowska, Magdalena Krajewska

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.01.060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Dorota Kamińska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland. Electronic address: dorota.kaminska@umw.edu.pl. Hauptthemen laut MEDLINE: Tacrolimus, Kidney Transplantation, Immunosuppressive Agents, Tremor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Tremor is common with tacrolimus treatment and is linked with peak blood drug concentrations. We investigated the effect of switching from immediate-release tacrolimus (IR-TAC) to MeltDose prolonged-release tacrolimus (LCPT) on tremor in kidney transplant recipients experiencing tremor at therapeutic levels of IR-TAC. METHODS: The Activities of Daily Living Subscale (ADL, range 0-48, lower = better) of the Essential Tremor Rating Scale was used to assess the effect of therapy change on speech, occupational impairment and social activities over a 12-month follow-up period. RESULTS: The study included 18 patients (mean age = 45.6 y, range 26-73; median (IQR) time from transplant = 1.1 y (0.6-1.5), with baseline IR-TAC trough concentrations (C0) ranging from 4.2 to 9.4 ng/mL (mean C0 = 6.7 ± 1.3 ng/mL). After the switch to LCPT, the mean ADL score improved from baseline 11.2 to 8.4 after 7 to 14 days (an 18% improvement, P < .001). This improvement was sustained after 3 months (ADL score = 5.0, 46% improvement vs baseline), 6 months (ADL score = 4.4, 48% improvement vs baseline), and 12 months (ADL score = 3.6, 63% improvement vs baseline); all P < .001. Despite a 40% reduction in LCPT daily doses (mean -1.9 mg/day compared to IR-TAC), the achieved C0 was constant during the course of the 12-month observation (P = .755). The renal function remained stable after conversion (eGFR 12 months vs baseline = +1.1 mL/min/1.73 m2, 95% CI: -5.6 to +7.9). CONCLUSION: Conversion to LCPT may alleviate symptom burden and improve daily activities in kidney transplant recipients experiencing tremor within therapeutic IR-TAC concentrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusKidney TransplantationImmunosuppressive AgentsTremorDelayed-Action PreparationsHumansMiddle AgedFemaleMaleAdultAgedActivities of Daily LivingTreatment Outcome

Substanzen

TacrolimusImmunosuppressive AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland. Electronic address: dorota.kaminska@umw.edu.pl.
  • Medical Department, Chiesi Poland Sp z o.o., Warsaw, Poland.
  • Department of Nephrology, Transplantology and Internal Diseases, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
  • Department of Nephrology, Transplantology and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Nephrology, Medical University of Lublin, Lublin, Poland.
  • Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.

Zitieren

APA

Kamińska, D., Hożejowski, R., Chamienia, A., Dębska-Ślizień, A., Idasiak-Piechocka, I., Oko, A., Baranowicz-Gąszczyk, I., Załuska, W., Mazanowska, O., & Krajewska, M. (2024). Conversion From Immediate-Release to Prolonged-Release Tacrolimus in Kidney Transplant Patients With Tremor: A Case Series Study. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.01.060

Vancouver

Kamińska D, Hożejowski R, Chamienia A, Dębska-Ślizień A, Idasiak-Piechocka I, Oko A, et al. Conversion From Immediate-Release to Prolonged-Release Tacrolimus in Kidney Transplant Patients With Tremor: A Case Series Study. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.01.060

BibTeX
@article{Kamiska2024,
  author = {Kamińska, Dorota and Hożejowski, Roman and Chamienia, Andrzej and Dębska-Ślizień, Alicja and Idasiak-Piechocka, Ilona and Oko, Andrzej and Baranowicz-Gąszczyk, Iwona and Załuska, Wojciech and Mazanowska, Oktawia and Krajewska, Magdalena},
  title = {Conversion From Immediate-Release to Prolonged-Release Tacrolimus in Kidney Transplant Patients With Tremor: A Case Series Study},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.01.060}
}
Kostenlos starten →